Moumita Ghosh
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stem Cells | 8 | 2021 | 594 | 2.120 |
Why?
| | Trachea | 6 | 2015 | 237 | 1.610 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 6 | 2024 | 1040 | 1.580 |
Why?
| | Bronchi | 4 | 2015 | 260 | 1.240 |
Why?
| | Phospholipases A | 7 | 2007 | 102 | 1.130 |
Why?
| | Epithelial Cells | 6 | 2017 | 1096 | 0.930 |
Why?
| | Airway Remodeling | 1 | 2024 | 64 | 0.850 |
Why?
| | Lung | 11 | 2022 | 4060 | 0.810 |
Why?
| | Cell Differentiation | 8 | 2021 | 1991 | 0.790 |
Why?
| | Cell Lineage | 5 | 2020 | 350 | 0.560 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2022 | 209 | 0.550 |
Why?
| | Regeneration | 3 | 2013 | 197 | 0.500 |
Why?
| | Cigarette Smoking | 1 | 2017 | 101 | 0.480 |
Why?
| | Stem Cell Transplantation | 1 | 2017 | 176 | 0.480 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2022 | 683 | 0.470 |
Why?
| | Carmustine | 1 | 2015 | 50 | 0.470 |
Why?
| | Lung Diseases | 1 | 2021 | 767 | 0.460 |
Why?
| | Respiratory Mucosa | 3 | 2015 | 321 | 0.420 |
Why?
| | Mice | 22 | 2023 | 17787 | 0.420 |
Why?
| | Cells, Cultured | 12 | 2021 | 4193 | 0.420 |
Why?
| | Antiprotozoal Agents | 1 | 2013 | 16 | 0.420 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2023 | 327 | 0.410 |
Why?
| | Arachidonic Acid | 6 | 2016 | 120 | 0.400 |
Why?
| | Lung Neoplasms | 4 | 2023 | 2526 | 0.400 |
Why?
| | Naphthalenes | 4 | 2017 | 60 | 0.380 |
Why?
| | Cytosol | 4 | 2007 | 226 | 0.360 |
Why?
| | Immunologic Factors | 1 | 2013 | 236 | 0.350 |
Why?
| | Keratin-14 | 1 | 2010 | 15 | 0.350 |
Why?
| | Smoking | 1 | 2018 | 1627 | 0.330 |
Why?
| | Animals | 24 | 2023 | 36940 | 0.310 |
Why?
| | Fibroblasts | 3 | 2013 | 996 | 0.290 |
Why?
| | Immunity, Innate | 2 | 2016 | 828 | 0.290 |
Why?
| | Mitochondria | 3 | 2013 | 948 | 0.280 |
Why?
| | Phospholipases A2 | 5 | 2016 | 80 | 0.280 |
Why?
| | Type C Phospholipases | 1 | 2007 | 74 | 0.260 |
Why?
| | Epithelium | 2 | 2018 | 313 | 0.250 |
Why?
| | Group IV Phospholipases A2 | 5 | 2013 | 47 | 0.250 |
Why?
| | Endosomes | 1 | 2006 | 136 | 0.230 |
Why?
| | beta Catenin | 2 | 2020 | 253 | 0.220 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4295 | 0.200 |
Why?
| | Dinoprostone | 1 | 2003 | 191 | 0.200 |
Why?
| | Integrin alpha6 | 2 | 2013 | 9 | 0.200 |
Why?
| | Alveolar Epithelial Cells | 2 | 2023 | 114 | 0.190 |
Why?
| | Environmental Exposure | 2 | 2024 | 579 | 0.190 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2167 | 0.180 |
Why?
| | Endothelial Progenitor Cells | 1 | 2020 | 20 | 0.170 |
Why?
| | Stem Cell Niche | 1 | 2020 | 54 | 0.160 |
Why?
| | Macrophages, Peritoneal | 2 | 2013 | 94 | 0.160 |
Why?
| | Adult Stem Cells | 1 | 2019 | 40 | 0.160 |
Why?
| | Neovascularization, Physiologic | 1 | 2020 | 179 | 0.160 |
Why?
| | Air Pollution | 1 | 2023 | 316 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 261 | 0.150 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 382 | 0.150 |
Why?
| | Humans | 21 | 2024 | 137585 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 192 | 0.150 |
Why?
| | Homeostasis | 2 | 2013 | 621 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 5757 | 0.140 |
Why?
| | Air Pollutants | 1 | 2023 | 430 | 0.140 |
Why?
| | Candida albicans | 2 | 2016 | 54 | 0.140 |
Why?
| | Macrophages, Alveolar | 2 | 2023 | 391 | 0.140 |
Why?
| | Time | 1 | 2018 | 83 | 0.140 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2019 | 434 | 0.140 |
Why?
| | Cellular Reprogramming | 1 | 2018 | 99 | 0.140 |
Why?
| | Smokers | 1 | 2018 | 145 | 0.130 |
Why?
| | Respiratory System | 1 | 2018 | 157 | 0.130 |
Why?
| | Cell Proliferation | 3 | 2013 | 2475 | 0.130 |
Why?
| | NIH 3T3 Cells | 1 | 2017 | 144 | 0.130 |
Why?
| | Lung Diseases, Fungal | 1 | 2016 | 13 | 0.130 |
Why?
| | Phenotype | 3 | 2020 | 3196 | 0.130 |
Why?
| | Golgi Apparatus | 2 | 2007 | 100 | 0.130 |
Why?
| | Candidiasis | 1 | 2016 | 56 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 434 | 0.130 |
Why?
| | Phagocytosis | 2 | 2009 | 380 | 0.130 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 385 | 0.120 |
Why?
| | Mitotic Index | 1 | 2015 | 25 | 0.120 |
Why?
| | Reactive Oxygen Species | 3 | 2013 | 622 | 0.120 |
Why?
| | Biopsy | 1 | 2018 | 1129 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2016 | 1272 | 0.110 |
Why?
| | Endoplasmic Reticulum | 2 | 2007 | 265 | 0.110 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2013 | 3 | 0.110 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 7 | 0.110 |
Why?
| | Thapsigargin | 1 | 2013 | 20 | 0.110 |
Why?
| | Neoplasm Grading | 1 | 2015 | 307 | 0.110 |
Why?
| | Cyclooxygenase 2 | 2 | 2006 | 178 | 0.110 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2013 | 43 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1081 | 0.110 |
Why?
| | Thromboplastin | 1 | 2013 | 74 | 0.110 |
Why?
| | Membrane Fluidity | 1 | 2013 | 11 | 0.110 |
Why?
| | Amino Acid Sequence | 3 | 2007 | 2139 | 0.110 |
Why?
| | Rats | 2 | 2017 | 5647 | 0.100 |
Why?
| | Reactive Nitrogen Species | 1 | 2013 | 21 | 0.100 |
Why?
| | Pyrrolidines | 1 | 2013 | 79 | 0.100 |
Why?
| | Clone Cells | 1 | 2013 | 265 | 0.100 |
Why?
| | Keratins | 1 | 2013 | 173 | 0.100 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 100 | 0.100 |
Why?
| | Ketocholesterols | 1 | 2012 | 7 | 0.100 |
Why?
| | Hydroxycholesterols | 1 | 2012 | 5 | 0.100 |
Why?
| | Cyclosporine | 1 | 2013 | 268 | 0.100 |
Why?
| | Protein Transport | 3 | 2012 | 445 | 0.100 |
Why?
| | Mice, Knockout | 6 | 2020 | 3015 | 0.090 |
Why?
| | Lysosomes | 1 | 2012 | 141 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2007 | 2900 | 0.090 |
Why?
| | Apoptosis | 3 | 2012 | 2553 | 0.090 |
Why?
| | Inflammation Mediators | 2 | 2016 | 513 | 0.090 |
Why?
| | Bromodeoxyuridine | 1 | 2010 | 79 | 0.090 |
Why?
| | Neutrophils | 1 | 2016 | 1238 | 0.080 |
Why?
| | Disease Progression | 1 | 2018 | 2757 | 0.080 |
Why?
| | Calcium | 2 | 2013 | 1199 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2828 | 0.080 |
Why?
| | Mitosis | 1 | 2010 | 192 | 0.080 |
Why?
| | Cell Line, Transformed | 2 | 2013 | 145 | 0.080 |
Why?
| | Phosphorylation | 3 | 2012 | 1759 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 1142 | 0.080 |
Why?
| | Female | 6 | 2022 | 73304 | 0.080 |
Why?
| | Cytokines | 2 | 2016 | 2085 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1092 | 0.080 |
Why?
| | Isoenzymes | 2 | 2013 | 304 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2012 | 528 | 0.070 |
Why?
| | Interleukin-8 | 1 | 2009 | 268 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2009 | 207 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1276 | 0.070 |
Why?
| | Phosphoinositide Phospholipase C | 1 | 2007 | 5 | 0.070 |
Why?
| | Oxidants | 1 | 2007 | 111 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2010 | 1178 | 0.070 |
Why?
| | Phospholipases A1 | 1 | 2006 | 1 | 0.060 |
Why?
| | Insecta | 1 | 2007 | 67 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5472 | 0.060 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2009 | 329 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 332 | 0.060 |
Why?
| | Catalysis | 1 | 2006 | 307 | 0.060 |
Why?
| | DNA Primers | 2 | 2003 | 515 | 0.060 |
Why?
| | Phosphatidylcholines | 1 | 2006 | 147 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2006 | 1353 | 0.060 |
Why?
| | Fungi | 1 | 2006 | 144 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2006 | 216 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2607 | 0.050 |
Why?
| | Alternative Splicing | 1 | 2006 | 229 | 0.050 |
Why?
| | Macrophages | 2 | 2012 | 1547 | 0.050 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 861 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 77 | 0.050 |
Why?
| | Hyperoxia | 1 | 2004 | 90 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2833 | 0.050 |
Why?
| | Binding Sites | 1 | 2006 | 1303 | 0.050 |
Why?
| | Desmoglein 3 | 1 | 2022 | 15 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2006 | 518 | 0.050 |
Why?
| | Cell Membrane | 1 | 2006 | 738 | 0.050 |
Why?
| | Base Sequence | 2 | 2003 | 2181 | 0.050 |
Why?
| | Keratin-5 | 1 | 2022 | 50 | 0.050 |
Why?
| | Formaldehyde | 1 | 2022 | 63 | 0.050 |
Why?
| | Necrosis | 2 | 2013 | 246 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1242 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2006 | 771 | 0.050 |
Why?
| | Cohort Studies | 2 | 2023 | 5742 | 0.050 |
Why?
| | Eicosanoids | 2 | 2016 | 62 | 0.050 |
Why?
| | Particle Size | 1 | 2023 | 394 | 0.050 |
Why?
| | PPAR gamma | 1 | 2022 | 182 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2004 | 491 | 0.040 |
Why?
| | Tubulin | 1 | 2022 | 144 | 0.040 |
Why?
| | Models, Molecular | 1 | 2006 | 1570 | 0.040 |
Why?
| | Particulate Matter | 1 | 2023 | 315 | 0.040 |
Why?
| | Up-Regulation | 1 | 2003 | 843 | 0.040 |
Why?
| | Enzyme Induction | 1 | 2019 | 90 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 226 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2023 | 614 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 2019 | 82 | 0.040 |
Why?
| | RNA | 1 | 2006 | 921 | 0.040 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 261 | 0.040 |
Why?
| | Vascular Remodeling | 1 | 2020 | 193 | 0.040 |
Why?
| | Membrane Proteins | 2 | 2020 | 1164 | 0.040 |
Why?
| | Male | 3 | 2022 | 67762 | 0.040 |
Why?
| | Blotting, Western | 2 | 2011 | 1226 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2004 | 927 | 0.030 |
Why?
| | Middle Aged | 1 | 2018 | 33479 | 0.030 |
Why?
| | Enzyme Activation | 2 | 2009 | 810 | 0.030 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 399 | 0.030 |
Why?
| | Egtazic Acid | 1 | 2013 | 40 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2013 | 122 | 0.030 |
Why?
| | Diglycerides | 1 | 2013 | 61 | 0.030 |
Why?
| | Chelating Agents | 1 | 2013 | 75 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 971 | 0.030 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 56 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2012 | 72 | 0.020 |
Why?
| | Cell Line | 2 | 2012 | 2847 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2012 | 84 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2019 | 940 | 0.020 |
Why?
| | Permeability | 1 | 2012 | 161 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 65 | 0.020 |
Why?
| | Oxidative Stress | 2 | 2012 | 1317 | 0.020 |
Why?
| | Cell Movement | 1 | 2016 | 967 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 188 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2011 | 78 | 0.020 |
Why?
| | Transgenes | 1 | 2011 | 180 | 0.020 |
Why?
| | Signal Transduction | 1 | 2004 | 5079 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2011 | 390 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2892 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 465 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 19 | 0.020 |
Why?
| | Amiloride | 1 | 2009 | 26 | 0.020 |
Why?
| | Cilia | 1 | 2011 | 178 | 0.020 |
Why?
| | Receptors, IgG | 1 | 2009 | 75 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2012 | 620 | 0.020 |
Why?
| | Culture Media, Serum-Free | 1 | 2009 | 48 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 86 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2009 | 150 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 767 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2007 | 43 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2007 | 39 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2007 | 87 | 0.020 |
Why?
| | Actins | 1 | 2009 | 416 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2007 | 113 | 0.020 |
Why?
| | rho GTP-Binding Proteins | 1 | 2007 | 60 | 0.020 |
Why?
| | Metalloporphyrins | 1 | 2007 | 103 | 0.020 |
Why?
| | Syk Kinase | 1 | 2006 | 21 | 0.020 |
Why?
| | Zymosan | 1 | 2006 | 65 | 0.020 |
Why?
| | Lectins, C-Type | 1 | 2006 | 67 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2007 | 328 | 0.020 |
Why?
| | Kinetics | 1 | 2009 | 1670 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2006 | 92 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2006 | 115 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 2007 | 346 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2007 | 500 | 0.010 |
Why?
| | Monocytes | 1 | 2007 | 563 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1774 | 0.010 |
Why?
| | Erythrocytes | 1 | 2009 | 700 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 584 | 0.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 455 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 2224 | 0.010 |
Why?
| | Spodoptera | 1 | 2002 | 40 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 596 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 534 | 0.010 |
Why?
| | Cell Survival | 1 | 2004 | 1120 | 0.010 |
Why?
| | Biomarkers | 1 | 2011 | 4149 | 0.010 |
Why?
| | Fatty Acids | 1 | 2002 | 443 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 840 | 0.010 |
Why?
| | Mutation | 1 | 2009 | 3958 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|